itraconazole has been researched along with Germinoblastoma in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 5 (41.67) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arsić Arsenijević, V; Barać, A; Crnčević Radović, L; Pekmezović, M; Trpković, A | 1 |
Griffiths, CA; Zambelli, AB | 1 |
Buck, A; den Hollander, J; Feuerstacke, Y; Hermann, K; Krainz, P; Meyer Zum Bueschenfelde, C; Peschel, C; Ringshausen, I | 1 |
Asaka, M; Imamura, M; Kahata, K; Kato, N; Ota, S; Tanaka, J; Toubai, T; Toyoshima, N; Umehara, S | 1 |
Besuden, M; Bode, U; Fleischhack, G; Glasmacher, A; Hasan, C; Kreutzberg, S; Lampe, D; Simon, A; Vezmar, S | 1 |
Fujishima, M; Fujishima, N; Hirokawa, M; Kameoka, Y; Saito, H; Saito, K; Sawada, K; Scott, SA; Takahashi, N; Ubukawa, K; Yamanaka, Y | 1 |
Johnson, SA; Oliver, DA; Phillips, MJ; Prentice, AG; Warnock, DW | 1 |
Amaddi, G; Ambrosetti, A; Bonesi, R; Cerù, S; Martini, N; Montresor, P; Murari, C; Piacentini, I; Pizzolo, G; Todeschini, G | 1 |
Fujihara, M; Kyo, T; Myoken, Y; Sugata, T | 1 |
Cheymol, G; Hardy, S; Isnard, F; Poirier, JM; Tilleul, P; Weissenburger, J | 1 |
Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T | 1 |
Bradford, GR; Prentice, AG | 1 |
3 trial(s) available for itraconazole and Germinoblastoma
Article | Year |
---|---|
Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients.
Topics: Adult; Bone Marrow Transplantation; Drug Administration Schedule; Female; Humans; Itraconazole; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Transplantation, Autologous | 1994 |
Plasma itraconazole concentrations in patients with neutropenia: advantages of a divided daily dosage regimen.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Drug Monitoring; Humans; Itraconazole; Leukemia; Lymphoma; Middle Aged; Mycoses; Neutropenia | 1997 |
Prophylaxis of fungal infections with itraconazole during remission-induction therapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Itraconazole; Ketoconazole; Leukemia; Lymphoma; Male; Middle Aged; Multicenter Studies as Topic; Mycoses; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies | 1989 |
9 other study(ies) available for itraconazole and Germinoblastoma
Article | Year |
---|---|
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Kidney Transplantation; Lymphoma; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Postoperative Complications; Serbia | 2012 |
South African report of first case of chromoblastomycosis caused by Cladosporium (syn Cladophialophora) carrionii infection in a cat with feline immunodeficiency virus and lymphosarcoma.
Topics: Animals; Antifungal Agents; Cats; Chromoblastomycosis; Cladosporium; Fatal Outcome; Feline Acquired Immunodeficiency Syndrome; Immunodeficiency Virus, Feline; Itraconazole; Lymphoma; Male; South Africa | 2015 |
Antifungal therapy with itraconazole impairs the anti-lymphoma effects of rituximab by inhibiting recruitment of CD20 to cell surface lipid rafts.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antigens, CD20; Antineoplastic Agents; Caspofungin; Drug Interactions; Echinocandins; Female; Humans; Itraconazole; Jurkat Cells; Lipopeptides; Lymphoma; Membrane Microdomains; Mice; Mice, SCID; Rituximab; Xenograft Model Antitumor Assays | 2010 |
[Itraconazole capsules as antifungal prophylaxis for neutropenic patients with hematological malignancies from a single institution].
Topics: Adolescent; Adult; Aged; Capsules; Drug Interactions; Female; Humans; Itraconazole; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Mycoses; Neutropenia; Prospective Studies | 2005 |
Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; Chemoprevention; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Itraconazole; Leukemia; Lymphoma; Male; Neoplasms; Neuroblastoma; Neutropenia; Prospective Studies; Stem Cell Transplantation | 2007 |
Itraconazole oral solution enhanced vincristine neurotoxicity in five patients with malignant lymphoma.
Topics: Administration, Oral; Aged; Drug Synergism; Female; Humans; Itraconazole; Lymphoma; Male; Middle Aged; Neurotoxicity Syndromes; Pharmaceutical Solutions; Vincristine | 2008 |
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies.
Topics: Administration, Intranasal; Administration, Oral; Adult; Air Microbiology; Amphotericin B; Aspergillosis; Aspergillus; Humans; Itraconazole; Leukemia; Lymphoma; Pilot Projects | 1993 |
Oral aspergillosis in compromised patients.
Topics: Adult; Aged; Aspergillosis; Chemoprevention; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Itraconazole; Leukemia, Biphenotypic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Mouth Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1996 |
Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; Drug Combinations; Drug Evaluation; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Leukemia; Lymphoma; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Neutropenia | 1999 |